来源：环球网 一家企业如何穿越周期？一个品牌如何定义未来？在充满不确定的时代，简单的规模扩张已非答案，价 格战更是饮鸩止渴。真正的破局，依靠洞察，依靠战略，依靠内功。 9月25日—26日，环球网与人民网、新华网等组成媒体团，走进了荣泰健康上海总部以及浙江南浔智慧 工厂，此行的目的，是为了探寻"全球主要的按摩椅制造商之一"的荣泰如何将"科技让生活更健康"的理 念落地为具体的产品和服务，并解码其"服务亿万用户"愿景背后的硬核实力。 在荣泰虹桥总部的分享会上，荣泰品牌运营事业部总经理吴小刚首先介绍了荣泰的历史和核心竞争力， 1997年成立的荣泰专注按摩领域近30年，以"更专业的按摩椅"为核心定位，其专业和实力主要体现在技 术领先、制造领先、渠道领先、服务领先四个方面。 技术是荣泰最为重要的核心竞争力。创立至今，荣泰历经6次重大技术迭代：在按摩导轨上，实现了从 无导轨到S型、SL型，再到更贴合人体曲线的"柔性导轨"的进化；在按摩机芯上，完成了从2D、3D到 4D机芯，再到"双机芯"的跃升。与此同时，在"换向零等待"、"360°玲珑腿足系统"以及"Bi-Stretch拉伸² 系统"等关键领域，荣泰也持续突破。 作为专精 ...

Core Viewpoint - 盈康生命 has demonstrated steady growth in a challenging industry environment, achieving a revenue of 843 million yuan, a year-on-year increase of 2.4%, and a net profit of 61.83 million yuan, up 12.8% [3] Group 1: Medical Services - The company is focusing on the construction of a tumor specialty service system integrated with artificial intelligence, transitioning from scale expansion to quality and efficiency [4] - The acquisition of Changsha Kexin Tumor Hospital enhances the company's tumor medical service capabilities in Central China, filling a strategic gap and potentially increasing future growth [5] - The tumor revenue from the medical services segment reached 214.95 million yuan, a year-on-year increase of 25.14%, with significant growth in outpatient visits and advanced surgical procedures [5][6] Group 2: AI Integration - 盈康生命 is one of the few medical groups to implement AI comprehensively, improving diagnostic efficiency and patient experience significantly [6][7] - AI applications have led to a 66% increase in image reading efficiency and a 300% improvement in follow-up efficiency for discharged patients, resulting in a high patient net promoter score (NPS) of 92.5% [7] Group 3: Medical Devices - The company is advancing its medical device segment through high-end upgrades and global expansion, achieving a 35% year-on-year increase in overseas revenue [8][9] - Key products have seen market share growth, with the infusion pump ranking third in the domestic market, and the company has established nine new overseas distributors [9] Group 4: Future Outlook - 盈康生命 is building a comprehensive health ecosystem through AI empowerment and industry collaboration, transitioning from a traditional medical service provider to a holistic health management platform [10]